News
The Accolade Skirt is so versatile that it quickly became one of my favorite pieces for looking put-together with minimal effort. It’s ideal for transitional weather since it can be paired with ...
Accolade Partners said it raised a total of more than $1 billion to invest in venture capital and growth equity funds. “This is a really good vintage to put money to work,” said Atul Rustgi ...
Transcarent and Accolade (ACCD) announced that they have entered into a definitive agreement under which Transcarent will acquire Accolade for $7.03 per share in cash, which represents a total ...
Accolade shareholders will receive $7.03 per share, a 110% premium over the stock’s Tuesday closing price of $3.35. The deal is expected to close in the second quarter of the year.
I wanted to love my Accolade sweat sets — and for more than $250 each, I should have —but despite keeping me cozy and on-trend this winter, these pieces just don’t live up to the hype.
Accolade is raising $175 million for Accolade Partners Blockchain II LP, its second crypto fund of funds, which will invest in about 10 crypto venture funds, said Atul Rustgi, a partner at the firm.
Accolade says the new service recognizes the “growing emotional and mental health crisis” impacting people and families during the COVID-19 pandemic.
SAN FRANCISCO & SEATTLE, January 08, 2025--Transcarent, the One Place for Health and Care, and Accolade (NASDAQ:ACCD), a leader in health advocacy, expert medical opinions, and primary care ...
Accolade’s new mobile app lets customers message their ehalth assistant and share documents. It is the first healthcare service of its kind to allow person-to-person messaging.
Transcarent acquires Accolade for $7.03 per share in cash, valuing the deal at $621 million, a 110% premium over its Jan. 7 stock price. The merger combines Transcarent's AI-powered care offerings ...
Health benefits platform Accolade has signed a definitive agreement to acquire virtual primary care company PlushCare for $450 million, according to a Friday statement. The combined companies plan ...
Transcarent, the One Place for Health and Care, and Accolade (ACCD) announced that they have entered into a definitive agreement under which Transcarent will acquire Accolade for $7.03 per share ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results